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1. Introduction 
Glutamate Dehydrogenase (GDH) catalyzes the oxidative conversion of glutamate to alpha 
ketoglutarate and ammonium supplying the TCA cycle with intermediates in support of 
anaplerosis (Figure 1 Rxn1). Conversely GDH catalyzes the reductive amination of alpha 
ketoglutarate and ammonium producing glutamate when the TCA cycle pool is filled. The 
net GDH flux resulting from these bidirectional fluxes can be obtained from the conversion 
of either 15N labeled glutamate and analyzing 15N ammonium or from 15N labeled NH4+ 
and monitoring 15N labeled glutamate. Besides deamination and 15N NH4+ production, 15N 
labeled glutamate can be converted to 15N labeled amino acids, most prominently alanine, 
via transamination reactions (Figure 1, Rxn2). In contrast to glutamate deamination which 
yields net keto acid production for anaplerosis [1], transamination does not yield net keto 
acid production (consuming a keto acid e.g. pyruvate in the process of generating alpha 
ketoglutarate). Under physiological conditions plasma glutamate concentration, 10-20uM, is 
limiting for GDH flux supplying TCA intermediates while plasma glutamine concentration, 
600uM, is not [2]. The conversion of 15N amide labeled glutamine to 15N ammonium 
(Figure1, Rxn1) approximates the net glutaminase flux generating glutamate and 
ammonium, both potential substrates for GDH. Indeed GDH can also incorporate the amide 
derived 15N ammonium and alpha ketoglutarate into glutamate (Figure 1, Rxn3, reductive 
amination) which can subsequently transaminate with pyruvate generating 15N alanine [3]. 
Noteworthy this glutaminolytic anabolic pathway providing glutamate has been proposed 
as the primary metabolic transformation in tumor cells [4]. Figure 1, Rxn 3 also illustrates 
how ammonium production from the 15N amide of glutamine may underestimate the true 
glutaminase flux; to the extent that this occurs, it contributes to differences in estimated net 
glutaminase fluxes between the chemically measured glutamine disappearance and 15N 
amide ammonium appearance. Glutamine labeled with 15N in the amino position provides 
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an assessment of net GDH flux (Figure 1,Rxn1) as 15N NH4+ and, or, ALT flux as 15N 
alanine produced(Figure1,Rxn2).  
 
Figure 1. GDH determines the fate of 15N glutamine. Pathways of glutaminolysis, net keto acid 
production and NH4+ produced per glutamine consumed ratio. [1] Deamidation coupled to GDH 
deamination yielding 2NH4+/Gln and net keto acid (αKG). [2] Deamination coupled to ALT-mediated 
transamination yielding 1 NH4+/Gln and no net acid production. [3] Deamidation coupled to GDH 
reductive amination and transamination yielding < 1 NH4+/Gln and net keto acid 
2. Glutamine is the major source of ammonium produced in  
cultured cells 
Because the bulk (≈90%),[1,3-5] of the ammonium produced by cells in culture derives from 
glutamine’s 2 nitrogen moieties (preformed DMEM media glutamate is <50uM) chemical 
measures of ammonium produced (after subtracting any ammonium produced in the 
absence of glutamine) and glutamine consumed offers an index of the GDH pathway 
activity. A ratio of 1, for example, would be consistent with glutamine metabolized by 
glutaminase with NH4+ released to the media and glutamate either released to the media or 
transaminated to amino acids e.g. alanine (Figure 1, Rxn2). In either case there is no net 
GDH flux and therefore no net generation of keto acids. In contrast a ratio of 2 
NH4+/glutamine (Figure 1, Rxn1) is consistent with glutamine metabolized by glutaminase 
and the glutamate produced metabolized by GDH yielding NH4+ and net keto acid 
(anaplerosis) for the TCA cycle(running in either the normal forward or reverse direction,[ 
6]). On the other hand, an NH4+ produced per glutamine consumed less than 1 (Figure 1, 
Rxn3) is consistent with glutaminase generating NH4+ from the amide nitrogen with 
reductive amination [3,4] catalyzed by GDH reducing the NH4+/Gln ratio to less than 1 
producing glutamate and consuming net keto acid (alpha ketoglutarate); subsequent 
transamination yields amino acids(e.g. alanine, aspartate) consuming keto acids 
(cataplerosis) containing the amide nitrogen of glutamine[3,4]. Normal breast cell line 
exhibits an NH4+/glutamine ratio less than 1[7] whereas cancerous breast cell lines exhibit a 
ratio greater than 1[7] consistent with a quantitative difference in bidirectional GDH fluxes 
between normal (reductive amination) and tumorigenic cells (oxidative deamination). In 
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addition, in vivo administered [2-(14)C] labeled glutamate was taken up by tumors with 14C 
distributed more into protein and lactate than in normal tissues [ 8 ]. In line with this early 
finding, a recent study[9] showed[U-(13)C] glucose contributed less than 50% of the acetyl 
COA pool in human brain tumors consistent with glutaminolysis and GDH’s role in 
maintaining TCA pool homeostasis (anaplerosis).  
3. Intracellular glutamate and alpha ketoglutarate are in near equilibrium 
In most cells intracellular glutamate and alpha ketoglutarate are in near equilibrium[4,10], 
and changes in TCA cycle intermediates(αKG) as well as the redox state(NADPH/NADP), 
energy charge(ADP,GTP) and cell pH shift the GDH catalyzed flux to net production or 
consumption of αKG (Figure 2). Normally pyruvate (glucose) provides the TCA cycle with 
pool intermediates while generated glutamate is transaminated (NH4+/GLN ratio<1, Figure 1 
Rxn3). In cancer cells, glucose is shunted into aerobic glycolysis (Warburg effect, [11]) and 
the TCA cycle intermediates are reduced as the result of cataplerosis as evidenced by lower 
intracellular glutamate [7]. This reduction in TCA cycle intermediates “pulls” glutamate 
through GDH generating αKG as evidenced by the higher steady state NH4+/GLN ratio>1, 
Figure 1, Rxn1 and consistent with glutamate (glutaminolysis) supporting anaplerosis 
(Figure 2). As a corollary, the ammonium to alanine produced ratio increases [7] reflecting 
the increased GDH and decreased ALT flux as the result of reduced intramitochondrial 
pyruvate(metabolized in cytosol to lactate, Figure 2). Thus the increased glutamate flux 
through GDH generates αKG while sparing keto acid consumption (reduced 
transamination).  
4. Glutamate is generated by extra- and intracellular glutaminases  
Glutaminolysis as illustrated in Figure 2 is associated with the increased expression of both 
the  extr ins ic  ce l l  membrane phosphate  independent  g lutaminase/gamma 
glutamyltransferase/gamma glutamyltranspeptidase (PIG, GGT, GGTP) which generates 
extracellular glutamate [2,12] and intracellular phosphate dependent glutaminases, 
Phosphate dependent glutaminases (PDG,GLS1 and GAC, [13,14]) which generates 
glutamate cytosolically [2,13]; extracellular glutamate can be transported(GLAST, Figure2) 
into the cytosol functioning as an inhibitor of the intracellular glutaminases[2]. Noteworthy, 
c-myc signaling up-regulates both the cell membrane glutamine transporter (ASC, Figure 2) 
and the intracellular glutaminases in cancer cells [15]. On the other hand, increased 
expression of the extracellular PIG is also a hallmark of cancer cells [16] and PIG hydrolysis 
of ϒ-glutamyl-tagged fluorescent markers can be used to delineate tumor boundaries [16]. 
However, in contrast to glutamine uptake, cell membrane glutamate transport (GLAST1) is 
shifted from the cell membrane to an intracellular location in breast cancer cells as shown in 
Figure 3, effectively uncoupling extracellular glutamate from inhibiting the intracellular 
glutaminases; this allows full blown expression of intracellular glutamate generation(Figure 
1RXI) and, if the relocated glutamate transporter, GLAST1 transports glutamate from the 




Figure 2. Central role of GDH flux in cancer cells. Glucose (GLC) derived pyruvate(PYR) is 
metabolized(Warburg effect) to lactic acid(LAC) at the expense of the TCA (tricarboxylic acid) cycle 
intermediate pool(αKG) “pulling” glutamate through GDH to supply anaplerosis. NHE(sodium 
hydrogen ion exchanger 1) mediated acid extrusion is up-regulated coupled to anaerobic glycolysis 
acidifying extracellular milieu while cell membrane glutamate transporter(GLAST1) relocates to 
mitochondria with PIG produced GLU- accumulating extracellularly and contributing with reduced 
pHe to host defense barrier. Glutamine(GLN) transported into cell by ASC and hydrolyzed to 
glutamate on outer surface of inner mitochondrial membrane by GAC [13] coupled with GLAST1. GLC 
removal (dashed line) accentuates GDH flux by “pull” mechanism while NHE mediated acid extrusion 
supported by GDH and accelerated αKG input with cytosolic malate(MAL) conversion to PYR 
supplying anaplerosis. TRO blocks PYR entry into mitochondria and accelerates GDH flux by 
exaggerated pull mechanism in conjunction with reduced pHi as result of NHE1 inhibition (“push” 
mechanism). EGCG inhibits GDH and induces cell death that can be partly rescued with methyl 
pyruvate(CH3-PYR) and restored TCA cycle pool while correction of cellular acidosis requires GDH 
flux pointing to the dual role for GDH in anaplerotic and acid base homeostasis. 
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then it would supply GDH glutamate in support of anaplerosis . Noteworthy  
overexpression of PIG promotes tumorigenesis [16] presumably by building up extracellular 
glutamate and suppressing local immune responses [18] . In addition NHE mediated acid 
extrusion is up-regulated in cancer cells [19,20] importing a Na+ load requiring Na+/K+ 
ATPase - ATP expenditure and ATP regeneration associated with acidogenic aerobic 
glycolysis(Warburg effect) and by substrate level phosphorylation. Because PIG 
(GGT/GGTP), NHE, glutamine transporter and glutaminase activities are all up-regulated in 
rapidly growing tumors, tagging molecular target inhibitors [21-24] with a ϒ-glutamyl 
moiety offers a tumor specific vehicle specific for limiting anaplerosis and preventing 
elevated cell pH, prerequisites for rapid tumor growth. 
 
Figure 3. GLAST localization in normal versus cancer cells. MCF10A and MCF7 cells cultured on 
coverglass were stained with monoclonal antibodies to GLAST-1 . MCF10A demonstrate almost 
complete membrane localization of the transporter, while MCF7 have a cytoplasmic distribution 
pattern. 
5. Glucose removal lowers TCA cycle intermediates and “pulls” 
glutamate through GDH       
Removal of glucose from the media (Figure 2, dotted gray line from GLC) deprives cells of 
pyruvate input into the TCA cycle and a fall in the intermediate (αKG) pool level[5] as reflected 
by a drop in glutamate [7]. As a consequence, GDH flux (Figure 1, Rxn1) increases [5] supplying 
anaplerosis as malate exits the cycle forming pyruvate which in turn supports citrate formation 
(Figure 2). Noteworthy this increased glutamate flux through GDH(“pulling” effect) is 
maintained by 2 responses:1] by a small increase in glutaminase flux [5,7] and, 2] a large fall in 
glutamate transamination [5,7,25].Under glucose deprivation cell survival is dependent on GDH 
flux at least in part to supply anaplerosis [5,26]. Surprisingly cell number actually increase in the 
glutamine (1.3mM) alone compared to the glucose(5mM) plus glutamine media (Figure 4A) 
because of reduced cell death; this increased survival is attributed to the increased GDH flux [26] 
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which besides supporting anaplerosis also enhances NHE mediated acid extrusion (Figure 4D) 
although proliferation rate decreases (Figure 4B). Noteworthy is the increase in cell 
biomass(protein, nucleic acids and lipid) dependent upon glutaminolysis supported anaplerosis 
as shown by the increased incorporation of 14C-U-glutamine into cell biomass (Figure 4C).The 
critical role of GDH flux in cell survival is evident from the massive cell death induced by GDH 
inhibition under glucose depleted conditions with 100uM EGCG [5,26], an inhibitor of GDH [5]. 
Although supplying TCA cycle intermediates e.g. methyl pyruvate (10mM,Figure 2) rescued 
cells with GDH inhibited [5,26], a significant fraction of the population succumbed associated 
with a reduced cell pH [26]. Parenthetically, methylpyruvate is a strong acid constituting a large 
acid load which requires supplementing the media with equal moles of bicarbonate (10mM). 
Nevertheless, even after the above base compensation, supplying anaplerotic substrates does not 
restore NHE activity [26] pointing to an important dual role for GDH in maintaining both 
anaplerosis and pH homeostasis [22] for cell survival.  
 
Figure 4. Physiological(1.3mM) glutamine concentration alone supports breast cancer cell survival 
associated with increased anaplerotic and acid extrusion function. 4A GLN increased cell number and 
decreased cell death compared to GLN plus 5mM glucose; 4B Gln slows cell proliferation compared 
with GLC+GLN; 4C GLN supports anaplerotic function[14C-U-L-glutamine incorporation into TCA 
precipitated cellular protein and lipid 4D GLN supports accelerated NHE activity when assayed with K 
10mM GLN as opposed to 10mM GLC 
 
Role of Glutamate Dehydrogenase in Cancer Growth and Homeostasis 35 
6. Cellular acidosis “pushes” glutamate through GDH 
Glutamate flux through GDH can be also be “pushed” by a fall in intracellular pH [27]. 
Whether this reflects a shift from GHD1 to GDH2 isoform [28] is not known but, if so, this 
“pushing effect” of reduced pH effect could be additive with the above “pulling effect” of a 
reduced TCA pool (Figure 2). Indeed in metabolic acidosis, the ambient condition 
surrounding cancer cells in vivo, kidney cells’ glutaminolysis is both “pushed”(reduced cell 
pHi, [27]) and “pulled”(inhibition of TCA, [29]) as a result of reduced TCA cycle pool size 
associated with true renal growth [30]. Interestingly enough, the in vivo kidney switches 
fuels from lactate to glutamine oxidation in metabolic acidosis[31] so that the anaplerotic 
glutaminolysis-GDH reactions matches [32] the cataplerotic reactions(CO2, biomass 
formation, [30,31] as does acid excretion (2NH4+/glutamine) and base(2HCO3-/glutamine) 
generation. Furthermore the pH-dependent enlistment of GDH2 isoform alone (push 
mechanism) or accompanying GDH 1 flux (anaplerosis driven pull mechanism) would 
provide regulatory options in responding to anaplerotic/cataplerotic and, or, acid /base 
demands in tumors. 
7. Glitazones accelerate GDH flux via the push/pull mechanism:  
A strategy for therapeutic intervention 
Fortuitously there are agents that can be employed to impose this push/pull mechanism on 
the GDH flux in cancer cells and thereby present a window of vulnerability (targeted 
inhibitors). The antihyperglycemic agents, troglitazone (Rezulin) and rosiglitazone 
(Avandia)  block pyruvate entrance into the TCA cycle(25,33] lowering αKG(glutamate,7,25] 
and accelerating GDH flux via this “pull” mechanism (Figure 2). Simultaneously, both 
troglitazone and rosiglitazone directly inhibit NHE [25,34] lowering pHi and driving GDH 
via the “push” mechanism (Figure 2). Noteworthy the glutaminase flux (glutamine 
disappearance) remains unchanged while the NH4+ production increases as the result of the 
increase in deamination flux (GDH Figure 1, Rxn1). Although resembling glucose 
deprivation (“pull” mechanism), troglitazone further increases the NH4+ production 
(additive “push+pull” mechanism) exceeding the fall in alanine production (“pull” 
mechanism alone). More specifically the accelerated GDH flux (“push+pull”) induced by 
troglitazone can be demonstrated using 15N amino labeled glutamine as shown in Figure 5; 
in contrast, another glitazone pioglitazone(Actos) activates GDH flux [34] solely by reducing 
cell pH(“push” mechanism) and consequently does not reduce alanine production [34]. 
Noteworthy troglitazone acutely inhibits GDH flux (0-3hrs) as the result of a fall in 
mitochondrial membrane potential( Ѱm) requiring accelerated GDH flux(3-24hrs) to fully 
restore the Ѱm [7], a response that is PPARγ independent [7,25] and possibly mitoNEET [35] 
dependent. Little recognized is the direct inhibition of NHE[20,34] by both troglitazone and 
rosiglitazone as well as indirect inhibition mediated through PPARγ suppression of NHE 
gene expression[20,36]; in contrast, pioglitazone does not inhibit NHE directly[34] rather 
acts indirectly through PPARγ[36]lowering cell pH[34] and accelerating GDH flux(“push” 
mechanism). In combination, TRO +PIO together exert an additive effect on GDH flux 
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presumably reflecting both TRO’s “pull” action and PIO’s PPARγ- mediated down-
regulation of NHE gene expression. Significantly, the dual effect of glitazones to increase 
GDH flux while reducing NHE activity decreases proliferation(NHE) but increases cell 
survival(GDH) resulting in only a slight decrease in cell number[26]. Nor does adding 
troglitazone to glucose deleted cells induce massive cell death since the effect on GDH flux 
is additive (further reducing TCA intermediates and cell pH, Figure 2) and although 
proliferative rates are decreased, survival is enhanced [26]. Under these conditions, e.g. cell 
survival mechanisms, inhibition of GDH is most effective in causing massive cell death as 
occurs with the GDH inhibitor EGCG [5] combined with troglitazone [26]. Although rescue 
of cells is partly possible by restoring anaplerosis with methyl pyruvate, failure to restore 
NHE activity and the cellular acidosis preclude full recovery underlining the importance of 








Figure 5. Ammonium production from amino nitrogen of glutamine. Cells were incubated for 18 
hours in [2-15N] glutamine. TRO was used at  20 uM, PIO 10 uM. Results are from 3 experiments.  
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